Gary W Pace Pacira Bio Sciences, Inc. (PCRX) insider trading activity

Gary W Pace is Director of Pacira BioSciences, Inc.. Currently has a direct ownership of 22,127 shares of PCRX, which is worth approximately $367,308. The most recent transaction as insider was on Mar 08, 2024, when has been sold 90,000 shares (Common Stock) at a price of $30.6 per share, resulting in proceeds of $2,754,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 22.1K

0% 3M change

84.36% 12M change

Total Value Held $367,308

GARY W PACE Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 08 2024	SELL Open market or private sale	$2,754,000 $30.6 p/Share	90,000 Reduced 80.27%	22,127 Common Stock
Mar 07 2024	SELL Open market or private sale	$870,598 $30.81 p/Share	28,257 Reduced 20.13%	112,127 Common Stock
Mar 06 2024	SELL Open market or private sale	$31,628 $29.67 p/Share	1,066 Reduced 0.75%	140,384 Common Stock
Jun 14 2023	BUY Grant, award, or other acquisition	-	1,775 Added 1.24%	141,450 Common Stock
May 11 2023	SELL Open market or private sale	$209,526 $41.78 p/Share	5,015 Reduced 3.47%	139,675 Common Stock
May 11 2023	BUY Exercise of conversion of derivative security	$209,300 $29.9 p/Share	7,000 Added 4.61%	144,690 Common Stock
Jun 08 2022	BUY Grant, award, or other acquisition	-	1,160 Added 0.84%	137,690 Common Stock
Mar 03 2022	BUY Exercise of conversion of derivative security	$75,670 $10.81 p/Share	7,000 Added 4.88%	136,530 Common Stock
Mar 01 2022	SELL Open market or private sale	$92,072 $67.75 p/Share	1,359 Reduced 1.04%	129,530 Common Stock
Mar 01 2022	BUY Exercise of conversion of derivative security	$14,976 $11.02 p/Share	1,359 Added 1.03%	130,889 Common Stock
Feb 28 2022	SELL Open market or private sale	$1,914,078 $66.83 p/Share	28,641 Reduced 18.11%	129,530 Common Stock
Feb 28 2022	BUY Exercise of conversion of derivative security	$315,624 $11.02 p/Share	28,641 Added 15.33%	158,171 Common Stock
Jun 09 2021	BUY Grant, award, or other acquisition	-	1,066 Added 0.82%	129,530 Common Stock
May 13 2021	SELL Bona fide gift	-	1,485 Reduced 1.14%	128,464 Common Stock

Also insider at

CRDF

Cardiff Oncology, Inc. Healthcare

Director

GWP

Gary W Pace

Director

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PCRX shares.

Notify only if

Value

Insider Trading

Get notified when an Pacira Bio Sciences, Inc. insider buys or sells PCRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Pacira BioSciences, Inc.

Track Activities on PCRX

Account